[107] In October 1998, Lilly formed a 50-50 joint venture with Icos, a Bothell, Washington-based biotechnology company, to develop and commercialize Tadalafil (Cialis), for the treatment of erectile dysfunction
Combining antioxidant-targeting agents with cell wall synthesis inhibitors has shown synergistic efficacy in model organisms, supporting combination therapies
Concentration of total RNA was measured by NanoDrop 2000C spectrophotometer followed by the reverse transcription using RT Reagent Kit (RR037B, Takara)
These centers are primary points for prescribing and monitoring oral GLP-1 therapies, ensuring patient safety and treatment adherence
Have you tried the new ones yet
Alcohol and caffeine consumption and decreased fertility